Increase the countercyclical adjustment of macro policies. A series of reform measures will be introduced next year. From the national development and reform work conference held by the National Development and Reform Commission, we learned that in order to fully implement the spirit of the Central Economic Work Conference, we will increase the countercyclical adjustment of macro policies next year, and solidly promote economic stability, structural improvement and development trend. The relevant person in charge of the National Development and Reform Commission said that a more active and promising macro policy will be implemented next year to enhance the consistency of macro policy orientation.The institution is optimistic about these stocks today. On December 13th, as of press time, the institution gave 20 latest buy ratings, among which the target price of 9 stocks was announced:-Cobos was optimistic about UBS Securities, giving a target price of 62.00 yuan; -Yingqu Technology was favored by Guotai Junan with a target price of 19.25 yuan; -Yutong Bus, Jinkong Coal Industry, Dong 'e Ejiao and many other stocks are listed.Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.
Nasdaq China Jinlong Index fell more than 2% in the day, while Nasdaq China Jinlong Index fluctuated lower, falling more than 2% in the day. Shells fell more than 5%, while iQiyi, New Oriental and Jinshan Cloud fell more than 4%.Morgan Stanley lowered the Nike target price from $82.00 to $80.00.Analyst: Britain's economic contraction for the second consecutive month sounded the alarm. AJ Bell analyst Danni Hewson said in a report that one month's data can't tell the whole story, but when the British economy contracted for two consecutive months-just like September and October-it is worthy of attention. The last time the economy contracted for two consecutive months was during the first pandemic blockade in 2020. She said that the uncertainty before the government budget may lead individuals and businesses to avoid spending for fear of possible tax increases. Bars, restaurants and art industries were hit hard in October. Hewson said that such discretionary expenses can be easily cut. In addition, looking back over the past six months, except August, the economic activity in each month was flat or decreased.
Japanese people protested against sexual violence by US troops stationed in Japan. On the evening of 13th, Japanese people held a rally outside the Japanese Foreign Ministry in Tokyo to protest against sexual violence by US troops stationed in Japan. (Xinhua News Agency)Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.Guangyunda: It is planned to raise no more than 448.9 million yuan from Junguang Investment. Guangyunda announced that the type of shares to be issued by the company to a specific target is domestic listed RMB ordinary shares (A shares) with a par value of RMB 1.00 per share. The object of issue is Shenzhen Junguang Investment Holding Co., Ltd., and the issue price is determined to be 7.74 yuan/share. The number of shares issued this time does not exceed 58 million shares (inclusive), which does not exceed 30% of the total share capital of the company before this issuance. The total amount of funds raised by the proposed stock issue to a specific target does not exceed RMB 448.92 million (inclusive), and the net amount of funds raised after deducting the issuance expenses is intended to be used to supplement the working capital. This proposal still needs to be submitted to the company's shareholders' meeting for consideration.